Vimarsana
Biggest News Aggregation in the World

Page 6 - Genevant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genevant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genevant Sciences Today - Breaking & Trending Today

Second judge says US not liable in Moderna COVID-19 vaccine patent case - Vimarsana News

Second judge says US not liable in Moderna COVID-19 vaccine patent case

By Blake Brittain (Reuters) - Moderna Inc failed to persuade a Delaware federal judge on Wednesday to shift liability to the U.S. government for paten...

Source: wkzo.com
US Not Liable in Moderna COVID-19 Vaccine Patent Case: Judge - Vimarsana News

US Not Liable in Moderna COVID-19 Vaccine Patent Case: Judge

Moderna failed to persuade a Delaware federal judge on Wednesday to shift liability from the company to the US government for alleged patent infringement by Moderna's COVID-19 vaccine.

Second judge says US not liable in Moderna COVID-19 vaccine patent case - Vimarsana News

Second judge says US not liable in Moderna COVID-19 vaccine patent case

Moderna Inc failed to persuade a Delaware federal judge on Wednesday to shift liability to the U.S. government for patent infringement allegations based on COVID-19 vaccines it provided for the... | April 26, 2023

Cancer Biotech Abdera Reveals $142M for Better Antibody-Based Radiation Drugs - Vimarsana News

Cancer Biotech Abdera Reveals $142M for Better Antibody-Based Radiation Drugs

Abdera Therapeutics emerged from stealth with technology that improves the way antibodies deliver radiopharmaceuticals for cancer. A lead program with preclinical proof-of-concept data in small cell lung cancer is on track to reach the clinic in 2024.

Update On Arbutus MRNA Vaccine Patent Litigations - Patent - Vimarsana News

Update On Arbutus MRNA Vaccine Patent Litigations - Patent

Last week, Arbutus Biopharma Corp. and Genevant Sciences GmbH (collectively, Arbutus) filed a complaint for patent infringement in the District of New Jersey against Pfizer, Inc. and BioNTech SE.

Source: mondaq.com